Inventor · disambiguated record
Dali Liang
Also filed as: LIANG DALI
0 granted patents·4 pending applications·0 citations·filing 2022–2023
Top patents by PatentIndex Score
4 records- 0160US2024174693A1Somatostatin receptor subtype 4 (sstr4) agonists and their applicationsHumanwell Pharmaceutical US·Filed 2023·Application pending·0 cites
- 0256US2025326755A1Cyclic quaternary ammonium salt compound, and preparation method therefor and use thereofYICHANG HUMANWELL PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0352US2024287021A1Quaternary ammonium salt compound, preparation method therefor and use thereofYICHANG HUMANWELL PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0452US2022354923A1Peptides for treatment of medical disordersHumanwell Pharmaceutical US·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dali Liang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →